Skip to main content
Caplight Logo









GCP ClinPlus

GCP ClinPlus

Private
BeijingHealthcare & Life Scienceshttps://www.gcpclinplus.com/

Last Round

Series B

Extension

Aug 5, 2025

Total Funding Raised

$14.86M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

GCP ClinPlus is a contract research organization (CRO) that provides end-to-end clinical trial services for pharmaceutical, biopharmaceutical, and medical device companies.

Sector

Healthcare & Life Sciences

Verticals

Clinical Trials, Biotechnology, Medical Devices, Compliance

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

contract research organizationCROclinical trial managementclinical operationsregulatory affairssite management organizationSMObiometricspharmacovigilanceclinical trial outsourcingfunctional service providerFSPdrug development servicesclinical data managementeclinical softwarechina clinical trialsbiotech outsourcing

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

GCP ClinPlus Comparables

Compare GCP ClinPlus with similar companies based on industry and business-model similarity.

GCP ClinPlus comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Quarkmed
89%
Bestudy (Shanghai) Medical Technology Co., Ltd.
89%
Hangzhou Tigermed Consulting Co., Ltd.
86%

GCP ClinPlus Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series B ExtensionAug 5, 2025
Series BJul 1, 2022
AngelAug 1, 2010

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 3, 2026

    Integrated with Probiocdmo to enhance trial predictability.

  • Aug 18, 2025

    Selected as CRO partner for OcuMension's anti-VEGF drug, OT-702.

GCP ClinPlus Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

GCP ClinPlus Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about GCP ClinPlus's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Year Founded2003
Last FundingAug 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?